Abstract
In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Current Drug Therapy
Title: In Situ Gels Based Drug Delivery Systems
Volume: 6 Issue: 3
Author(s): Madhugiri P. Venkatesh, Purohit K. Liladhar, Teggin M.P. Kumar and Hosakote G. Shivakumar
Affiliation:
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Abstract: In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Export Options
About this article
Cite this article as:
P. Venkatesh Madhugiri, K. Liladhar Purohit, M.P. Kumar Teggin and G. Shivakumar Hosakote, In Situ Gels Based Drug Delivery Systems, Current Drug Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488511796392004
DOI https://dx.doi.org/10.2174/157488511796392004 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Vascular Endothelial Growth Factor and Angiopoietins in Neurovascular Regeneration and Protection Following Stroke
Current Neurovascular Research Polymeric Nanoparticles for Ophthalmic Drug Delivery: An Update on Research and Patenting Activity
Recent Patents on Nanomedicine Efficient Expression and Purification of Recombinant Therapeutic Protein Candidates, Human Midkine and Pleiotrophin
Current Pharmaceutical Biotechnology A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Current Drug Therapy Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery
Current Diabetes Reviews Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features
Current Neurovascular Research Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders
Current Pharmaceutical Design The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials “PARG Inhibitors’ Success: A Long Way to Go!”
Current Enzyme Inhibition Modern drug delivery systems for targeting the posterior segment of the eye
Current Pharmaceutical Design Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma
Mini-Reviews in Medicinal Chemistry Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
Current Alzheimer Research Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Intravitreal Steroids for the Prevention of PVR After Surgery for Retinal Detachment
Current Pharmaceutical Design Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy Intravitreal Dexamethasone Implant <i>versus</i> Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial
Current Drug Delivery